SYSTEMIC VERSUS LOCAL TREATMENT WITH RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA (RTNF-ALPHA) IN PATIENTS WITH ADVANCED MALIGNANCIES

被引:10
作者
BARTSCH, HH
PFIZENMAIER, K
SCHRODER, M
NAGEL, GA
机构
[1] UNIV GOTTINGEN,ZENTRUM INNERE MED,MAX PLANCK GESELL,D-3400 GOTTINGEN,FED REP GER
[2] UNIV GOTTINGEN,HALS NASEN OHRENHEILKUNDE ABT,D-3400 GOTTINGEN,FED REP GER
来源
ONKOLOGIE | 1989年 / 12卷 / 03期
关键词
D O I
10.1159/000216621
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:136 / 141
页数:6
相关论文
共 46 条
[1]  
AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
[2]  
BARTSCH H H, 1988, Molecular Biotherapy, V1, P21
[3]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[4]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[5]  
BEUTLER BA, 1985, J IMMUNOL, V135, P3972
[6]  
BLICK M, 1987, CANCER RES, V47, P2986
[7]  
BRANDY VC, 1986, P NATL ACAD SCI USA, V83, P7467
[8]  
BROXMEYER HE, 1986, J IMMUNOL, V136, P4487
[9]   ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].
CARSWELL, EA ;
OLD, LJ ;
KASSEL, RL ;
GREEN, S ;
FIORE, N ;
WILLIAMSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670
[10]  
CREAVEN PJ, 1987, CANCER CHEMOTH PHARM, V20, P137